"CLINICAL FEATURES OF IMPAIRMENT OF SMELL AND TASTE IN COVID - 19"
Keywords:
COVID - 19, anosmia, hyposmia, dysgeusia, ageusia, clinical featuresAbstract
All doctors know that viral respiratory diseases can be manifested by ageusia (hypogeusia) and anosmia. (hyposmia) due to viral neurotropism, they usually appear along with other symptoms in the acute phase and in most cases have both good and short recovery.
The early articles on the clinical manifestations of COVID-19 and the systematic reviews based on them did not report on impairment of smell and taste. Only one of the earliest reports from Wuhan province mentions that there are 5.1% and 5.6% of COVID-19 patients with smell and taste disorders, respectively [1]. After that, scientists conducted numerous studies and concluded that hypo / anosmia is a very common and indicative manifestation of COVID-19 and alertness to these symptoms will help to timely identify individuals who are involuntary carriers of the infection. Based on this, we strive to describe the prevalence and features of anosmia and dysgeusia in patients with COVID-19 in the Tashkent region, Uzbekistan.
References
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in
the respiratory failure of COVID-19 patients. J Med Virol. 2020;10.1002/jmv.25728. doi:10.1002/jmv.25728
Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients
with COVID-19 in Wuhan, China: a retrospective cohort study // Lancet. 2020. Vol. 395. P. 1054–1062.
Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections:
epidemiological, clinical, and immunological features and hypotheses. Cell Stress. 2020. 10.15698/cst2020.04.216
WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11-
March-2020 [Internet]. [cited 2020 March 23].Available from: https://www.
who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19-.11-march-2020.
The Neuroinvasive Potential of SARS-CoV2 May Play a Role in the Respiratory Failure
of COVID-19 patients.-PubMed-NCBI [Internet]. [cited 2020 April 17]. Available
+COVID-19+patients.
Eliezer M, Hautefort C, Hamel AL, et al.: Sudden and Complete Olfactory Loss
Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck
Surg. 2020.PubMed Abstract | Publisher Full Text
Menni C, Valdes A, Freydin MB, et al.: Loss of smell and taste in combination
with other symptoms is a strong predictor of COVID-19 infection. medRxiv.
Publisher Full Text
Рахимбаева Гульнора Саттаровна, Шодиев Улуғбек Дониёр ўғли. Постковид цeрeбро-астeник синдром: диагностик йондашувларни оптималлаштириш, долзарб жихатлари // Журнал неврологии и нейрохирургических исследований №2.2021. 6-10 бет.
Туйчиев Л.Н., Рахимбаева Г.С., Газиева Ш.Р., Атаниязов М.К. Новая коронавирусная ин¬фекция и постковидные неврологиче¬ские последствия заболевания // Вестник ТМА № 2, 2021. 45-50 стр.
Атаниязов Махсуджан Камаладдинович, Рахимбаева Гульнора Саттаровна, Газиева Шохида Рустамовна. Характерные особенности инсульта при covid-19 // Журнал неврологии и нейрохирургических исследований №2.2021.14-17 стр
